Citadel Advisors’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$704K Sell
2,726
-383,779
-99% -$102M ﹤0.01% 8483
2025
Q4
$95.3M Sell
386,505
-250,483
-39% -$52.7M 0.06% 900
2025
Q3
$112M Buy
636,988
+602,428
+1,743% +$90.2M 0.09% 759
2025
Q2
$4.75M Buy
34,560
+34,464
+35,900% +$5.06M ﹤0.01% 4199
2025
Q1
$17.3K Sell
96
-10,919
-99% -$1.84M ﹤0.01% 13246
2024
Q4
$1.73M Buy
11,015
+10,919
+11,374% +$1.94M ﹤0.01% 5937
2024
Q3
$17.5K Buy
+96
New +$18.5K ﹤0.01% 12883
2024
Q2
Sell
-25,014
Closed -$4.2M 14968
2024
Q1
$4.45M Buy
25,014
+16,815
+205% +$2.34M ﹤0.01% 4123
2023
Q4
$1.02M Buy
8,199
+3,809
+87% +$422K ﹤0.01% 6643
2023
Q3
$509K Sell
4,390
-34,898
-89% -$4.26M ﹤0.01% 8039
2023
Q2
$4.61M Sell
39,288
-68,037
-63% -$6.95M 0.01% 3763
2023
Q1
$8.59M Buy
107,325
+54,649
+104% +$4.29M 0.01% 3001
2022
Q4
$4.17M Buy
52,676
+43,938
+503% +$3.26M ﹤0.01% 4170
2022
Q3
$609K Buy
+8,738
New +$631K ﹤0.01% 8037
2022
Q2
Sell
-8,732
Closed -$543K 13654
2022
Q1
$581K Sell
8,732
-30,013
-77% -$1.87M ﹤0.01% 9034
2021
Q4
$2.71M Buy
38,745
+7,742
+25% +$451K ﹤0.01% 5533
2021
Q3
$1.62M Buy
+31,003
New +$1.84M ﹤0.01% 6893
2021
Q2
Hold
0
14139
2021
Q1
Sell
-28,708
Closed -$2.09M 13543
2020
Q4
$1.72M Buy
28,708
+4,484
+19% +$224K ﹤0.01% 5671
2020
Q3
$1.04M Buy
24,224
+2,595
+12% +$113K ﹤0.01% 5956
2020
Q2
$896K Sell
21,629
-520,073
-96% -$25M ﹤0.01% 6032
2020
Q1
$23.4M Buy
541,702
+4,855
+0.9% +$254K 0.04% 1107
2019
Q4
$29.7M Sell
536,847
-1,379
-0.3% -$67.7K 0.04% 1133
2019
Q3
$18.7M Buy
538,226
+41,056
+8% +$1.84M 0.02% 1531
2019
Q2
$20M Buy
497,170
+174,296
+54% +$5.7M 0.02% 1431
2019
Q1
$10.6M Sell
322,874
-12,155
-4% -$287K 0.01% 1995
2018
Q4
$6.96M Buy
+335,029
New +$7.01M 0.01% 2331

Other funds holding KRYS